about
Methicillin-resistant Staphylococcus aureus therapy: past, present, and futureManagement of multidrug-resistant enterococcal infectionsChemical biology of tetracycline antibioticsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Systems and Chemical Biology, and has undergone the Journal's usual peer review process.Ocular penetration of topically applied 1% tigecycline in a rabbit model.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi.CIEF separation, UV detection, and quantification of ampholytic antibiotics and bacteria from different matrices.Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach.Tigecycline: a critical update.RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.Tigecycline inhibits proliferation of Acanthamoeba castellanii.Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii.Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.Exposure to subthreshold dose of UVR-B induces apoptosis in the lens epithelial cells and does not in the lens cortical fibre cells.
P2860
Q27011165-FBA765C1-EFA5-42BF-80DF-64A1AE8A6AF9Q28285907-14871D2F-737F-4B90-947A-77B7922C074CQ29030024-1C687ABB-6C66-4098-B255-E0D6300C98EFQ33706051-F6FE8F3D-7236-4274-9F04-9376DB6FE230Q35044119-70D9E919-8D93-47CA-A972-593F00741614Q35095320-FC745373-38FE-4AA5-8E0F-9E649D5EDD74Q35216676-FDA8D5F2-5C73-4E3A-9BA5-F81CBB47F493Q35542062-4B24A35C-84CC-45B5-A66B-48CAAE9511B3Q36772071-1C501856-A445-46B7-B25A-E2D9AA09AD6FQ36949625-0915EA44-099B-45A7-9C56-40B3CBDC5A30Q37233932-B8981F69-3502-412E-BA9F-92F4DE386C37Q37395680-3CA0B959-06E0-4E2E-9070-85FD99EBAFC3Q37949391-1AB1630C-7E9C-4849-AE79-6732510D6C23Q41560501-67870786-65AC-49BB-9ED9-27D813C53691Q41817951-04E985E1-705E-4F2B-BFFE-505E873132F2Q43127750-9293E375-44F7-4B70-95C3-BB743B922AEAQ43169364-6262BC9B-1C8E-44F2-8A0C-4A9B0B440203Q46274310-2608CAAD-540F-4031-93FC-CBEDC4803375Q47891552-9E90D349-C54C-4B06-9CBE-1A1F51A1F66D
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Tigecycline: a novel broad-spectrum antimicrobial.
@ast
Tigecycline: a novel broad-spectrum antimicrobial.
@en
Tigecycline: a novel broad-spectrum antimicrobial.
@nl
type
label
Tigecycline: a novel broad-spectrum antimicrobial.
@ast
Tigecycline: a novel broad-spectrum antimicrobial.
@en
Tigecycline: a novel broad-spectrum antimicrobial.
@nl
prefLabel
Tigecycline: a novel broad-spectrum antimicrobial.
@ast
Tigecycline: a novel broad-spectrum antimicrobial.
@en
Tigecycline: a novel broad-spectrum antimicrobial.
@nl
P2093
P2860
P356
P1476
Tigecycline: a novel broad-spectrum antimicrobial.
@en
P2093
Christine M Slover
Keith A Rodvold
Larry H Danziger
P2860
P304
P356
10.1345/APH.1H543
P407
P577
2007-05-22T00:00:00Z